Sun Pharmaceutical Industries Inc: Perampanel Ciii Tablets, 6mg
Recall Summary Sun Pharmaceutical is recalling Perampanel 6mg tablets nationwide because some bottles labeled as containing 6mg tablets were found to contain 10mg tablets instead. This labeling mix-up affects patients who may have taken a higher dose than prescribed. The affected product is NDC 51672-4206-6, a 30-tablet bottle distributed across all U.S. states and Washington, D.C.
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC
- Product
- Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6
- Reason
- Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-17
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/e9c807d2-bc89-4946-8f10-4a7711de3704